Page last updated: 2024-08-23

staurosporine and Carcinoma, Neuroendocrine

staurosporine has been researched along with Carcinoma, Neuroendocrine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonelli, A; Botta, L; Coviello, V; Da Settimo, F; Fallahi, P; Ferrari, SM; Hsing-Pang, H; Ke, YY; La Motta, C; La Pietra, V; Marinelli, L; Moriconi, A; Novellino, E; Quattrini, L; Sartini, S1

Other Studies

1 other study(ies) available for staurosporine and Carcinoma, Neuroendocrine

ArticleYear
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Structure-Activity Relationship; Thyroid Gland; Thyroid Neoplasms

2018